Cholangiocarcinoma
Conditions
Interventions
experimental group:Radiofrequency ablation 2 times
control group:????1?
Sponsors
Department of Hepatopancreatobiliary Surgery, the First Hospital of Jilin University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Malignant stenosis of common bile duct, unresectable malignant tumor; (2) ECOG score is 0-2 points, or KPS score >= 70 points; (3) Be older than 20 years old and less than 80 years old; (4) The estimated survival period is more than 3 months; (5) Meet the following laboratory diagnostic indicators: hemoglobin (HGb) >= 60g / L, white blood cells (WBC) >= 2.0 x 10^9 / L, neutrophils >= 0.6 x 10^9 / L, platelets (PLT) >= 100 x 10^9 / L; Creatinine (Cr) <= 1.2 x normal upper limit (UNL); (6) CT / MR showed clear bile duct mass and clear diagnosis; (7) Informed and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with severe heart, lung, and brain dysfunction and absolute contraindications to surgery; (2) Those with poor coagulation status; (3) Large amount of ascites, or extensive metastasis in the abdominal cavity, or distant metastasis in other parts of the body; (4) Participate in other clinical trials; (5) Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival;Bile duct patency time;Point-in-time survival;Quality of Life;Complication; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cause of death; | — |
Countries
China
Contacts
Public ContactKai Liu
The First Hospital of Jilin University
Outcome results
None listed